Landos Biopharma, Inc. (LABP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Landos Biopharma, Inc., with annual and quarterly history.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.05x | -0.53x | -5.05x | -15.97x | -34.54x | -79.62x |
| P/B Ratio | 0.72x | 0.51x | 2.53x | -8.91x | -18.81x | 481.21x |
| P/S Ratio | 0.00x | 0.00x | 10.73x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 98.9% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | -215.6% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | -212.4% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | -214.6% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.09x | 7.39x | 5.55x | 2.71x | 16.56x | 1.39x |
| Quick Ratio | 6.09x | 7.39x | 5.55x | 2.58x | 16.56x | 1.39x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..